Full-year 2025 worldwide sales were $94.2 billion, up 5.3% operationally despite an approximate 620 basis point headwind from Stelara. U.S. growth was 6.9% and growth outside the U.S. was 3.4%. Acquisitions and divestitures contributed 110 basis points, driven primarily by the Intra-Cellular and Shockwave acquisitions.For the quarter, net earnings were $5.1 billion and diluted EPS was $2.10 versus $1.41 a year earlier. Adjusted net earnings were $6.0 billion and adjusted diluted EPS was $2.46, representing ...